IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Documents
Speciality Medicines IPO listing price is [●], issue price is [●], and currently trading at [●] as on [●]. Speciality Medicines IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Speciality Medicines IPO is a Book Building listing on BSE SME exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Ekadrisht Capital is the merchant banker of Speciality Medicines IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 14th August 2024.
Speciality Medicines IPO offer price is [●] and got listed at [●]. Read Speciality Medicines IPO details mentioned above.The IPO of Speciality Medicines Limited was listed on [●]. As of today, Speciality Medicines IPO is trading at [●], compared to the previous day’s close of [●]. Read the report above for detailed IPO performance.
The issue price of Speciality Medicines IPO was [●] per equity share.
Speciality Medicines IPO was listed at ₹ on the stock exchange on [●]. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of [●], the current market price of Speciality Medicines IPO is [●].
The 52-week high for Speciality Medicines IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Speciality Medicines IPO listed at [●] against the issue price of [●] per equity share, showing a listing day gain/loss of -1 (-100.00%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Speciality Medicines IPO stock moved from its listing price of [●] to the current price of ₹[●] per equity share, reflecting a change of 0.00% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Speciality Medicines IPO issue date of [●] and CMP of ₹[●], the estimated CAGR is approximately 0%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
[●]
Listing Price :
[●]
Previous Day Closing
[●]
Speciality Medicines IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Speciality Medicines Financial Review Page
Merchant Banker(s) of Speciality Medicines IPO: Ekadrisht Capital Private Limited
Speciality Medicines IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Speciality Medicines IPO listed at a listing price of against the offer price of .
The current market price of Speciality Medicines is .
Why Us?
